FIFA report on Russia’s 2018 World Cup bidding proves legitimacy of its win — deputy PMSport June 27, 21:08
FIFA report on Russia’s 2018 bidding dismisses Western media allegations — LOC chiefSport June 27, 19:53
Kremlin says its computers not affected by hacker attackRussian Politics & Diplomacy June 27, 18:55
Security experts urge Putin, Trump to overcome disagreementsWorld June 27, 18:51
Jury to deliver verdict on Nemtsov murder case on June 28Society & Culture June 27, 18:42
Syrian president visits Russia’s Khmeymim airbaseWorld June 27, 18:17
National Guard to complete assigned missions both in Russia and abroadMilitary & Defense June 27, 18:10
Key facts about St. Petersburg International Maritime Defense ShowMilitary & Defense June 27, 17:57
Rosneft, Mars and Nivea are among victims of massive cyber attack in RussiaBusiness & Economy June 27, 17:04
LOS ANGELES, Oct. 9, 2013 /PRNewswire/ -- Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and the patentee of damaged organ regeneration- a top priority claimed in President Obama's 2013 State of the Union, addresses the ongoing lawsuit against Nobel Committee and its continuous false advertisement of fake pluripotent stem cell during the past year since Dr. Xu initially filed his lawsuit against the Academy citing, among other claims, libel and unfair competition.
Given the winners of 2013 Nobel Prize in Physiology or Medicine were disclosed this week and the Nobel Assembly has not yet made any clarification on its 2012 Prize in Medicine while continuing with its endorsement and false advertisement of fake pluripotent stem cells, Dr. Xu had to come out and tell the public why he sued the Nobel Assembly in 2012 and the progress of the lawsuit.
On October 8, 2012, The Nobel Assembly awarded the Nobel Prize in Physiology or Medicine to Shinya Yamanaka and another expert in nuclear transfer for artificially creating the pluripotency of human somatic cells. In the awarding press release and advertising documentary, the Nobel Assembly stated clearly that the prize winner successfully converted somatic cells into pluripotent stem cells by reprogramming genes. But the winner himself did not acknowledge he produced pluripotent stem cells from somatic cells (tissue cells), "My current research focuses on ways to generate cells resembling embryonic stem cells by reprogramming somatic, or skin, cells. I was awarded the 2012 Nobel Prize in Physiology or Medicine for my discovery that adult somatic cells can be reprogrammed into pluripotent cells," claimed Yamanaka in his declaration. On the other hand, the first claim of Dr. Xu's organ regeneration application patent (US6991813) shows that human somatic cells, cultured in regenerative nutritional substances, can be converted in situ into pluripotent stem cells (keratin 19 expressing stem cells) and regenerate physiological tissues and organs in situ. This procedure has been accomplished in human use. Therefore, Dr. Xu has demonstrated that the human body has the innate regenerative potential to convert somatic cells into pluripotent stem cells; this regenerative potential is not created artificially.
On December 3, 2012, Dr. Xu sued the Nobel Assembly because of its false and misleading reporting has slandered Dr. Xu's reputation and the vendibility of his patents. Dr. Xu has also publically requested the Nobel Assembly to clarify whether the human regenerative potential by conversion into pluripotent stem cells is innate or created artificially by the Nobel prize winner. "Because this is a principle issue regarding the authenticity of life science and this point has to be clarified. This lawsuit is not only for my title to patent, but also for disclosing the truth of human regenerative potential on behalf of the public," said Dr. Xu, "In almost one year after my submission of the lawsuit against the Nobel Assembly, they have not yet had any response to aforementioned scientific principle issue. Instead, they have delayed the suit by removing the case to a federal court in the same area. In the meanwhile, they produced a documentary video covering the introduction of fake pluripotent stem cells and used it to further promote its misleading information on TV. In this period, my attorney informed me about the Nobel Assembly's invitation for a meeting to discuss the possibility of a settlement. While we would consider settlement as one of the options, because we just want to protect our rights by asking the Nobel Assembly to make a clarification on whether Yamanaka created a real pluripotent stem cell or fake pluripotent stem cell; we have no intention to undermine the reputation of the Nobel Assembly, but the filing of a suit was the only way which we could compel the Nobel Assembly to provide a response."
On May 8, 2013, Dr. Xu filed a lawsuit against Dr. Shinya Yamanaka, one of the winners of the 2012 Nobel Prize in Physiology or Medicine, for that the cell produced by Yamanaka using reprogramming method is a fake pluripotent stem cell, while Yamanaka named it "induced pluripotent stem cell (iPSC)" in his research and promote his fake pluripotent stem cell using the name and function of real pluripotent stem cell, do fraud with the name of iPSC. Therefore, Dr. Xu sued Yamanaka and asked the Court to grant a relief which would require Yamanaka to refrain from using the terms of real pluripotent stem cell or iPSC to describe his fake pluripotent stem cell. Yamanaka acknowledged in his declaration that "If granted, this declaratory and injunctive relief would severely undermine my reputation in the scientific community, undermine our life-saving research, and cripple our ability to obtain funding for this research. The damage to my reputation, intellectual property, research, and income would certainly far exceed $75,000 if the relief requested by the Plaintiffs were granted."
From Dr. Xu's perspective, by employing the name of pluripotent stem cells both the Nobel Assembly and Dr. Yamanaka have committed false advertising. They do so to enhance the prestige of the prize and benefit from popularizing the fake pluripotent stem cell, respectively. Dr. Xu is steadfast in clarifying the defendants' conduct of false advertisements and unfair competition by continuous legal suits, no matter wherever they are and how many interest groups are involved, whereby to restore the authenticity and safety of scientific community.
About Dr. Rongxiang Xu
Dr. Rongxiang Xu is the founder of "Human Body Regenerative Restoration Science" (HBRRS), a renowned life scientist and medical scientist and chairman of the board of MEBO International, a California and Beijing based intellectual property Management Company responsible for managing HBRRS. Dr. Xu is also a standing Member of the Chinese Medical Doctor Association, and Honorable Chairman of the Chinese Burn Association of the Integration of Traditional and Western Medicine.
For more information on Dr. Xu, visit www.mebo-international.com